Trial Profile
Liraglutide versus insulin detemir , the effective switch from intensive insulin therapy to the once-daily injection in patients with well controlled type 2 diabetes : a randomized controlled trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Jul 2017
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary) ; Liraglutide (Primary) ; Glimepiride; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 09 Jul 2017 Status changed from recruiting to completed.
- 09 Jan 2012 New trial record